NDAINTRAVENOUSSOLUTION
Approved
Jun 2017
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
2
Mechanism of Action
level. Calcium gluconate dissociates into ionized calcium in plasma. Ionized calcium and gluconate are normal constituents of body fluids.
Clinical Trials (2)
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
Started Jun 2010
362 enrolled
Chemotherapeutic Agent ToxicityColorectal CancerNeuropathy+1 more
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery
Started Jan 2006
104 enrolled
Colorectal CancerNeurotoxicity
Loss of Exclusivity
LOE Date
Jul 25, 2037
138 months away
Patent Expiry
Jul 25, 2037
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 10130646 | Jul 25, 2037 | Product | — |